Physical activity and exercise outcomes in Huntington Disease (PACE-HD): Protocol for a 12-Month trial within cohort evaluation of a physical activity intervention in people with Huntington Disease

Drew, Cheney J G ORCID: https://orcid.org/0000-0002-4397-6252, Quinn, Lori ORCID: https://orcid.org/0000-0002-2982-923X, Hamana, Katy ORCID: https://orcid.org/0000-0001-5213-253X, Williams-Thomas, Rhys, Marsh, Lucy, Dimitropoulou, Polyxeni, Playle, Rebecca ORCID: https://orcid.org/0000-0002-2989-1092, Griffin, Beth Ann, Kelson, Mark ORCID: https://orcid.org/0000-0001-7744-3780, Schubert, Robin, Muratori, Lisa, Reilmann, Ralf, Rosser, Anne ORCID: https://orcid.org/0000-0002-4716-4753 and Busse-Morris, Monica ORCID: https://orcid.org/0000-0002-5331-5909 2019. Physical activity and exercise outcomes in Huntington Disease (PACE-HD): Protocol for a 12-Month trial within cohort evaluation of a physical activity intervention in people with Huntington Disease. Physical Therapy 99 (9) , pp. 1201-1210. 10.1093/ptj/pzz075

PDF - Accepted Post-Print Version Download (549kB)

Abstract

Background Exercise is emerging as an important aspect in the management of disease-related symptoms and functional decline in people with Huntington disease (HD). Long-term evaluation of physical activity and exercise participation in HD has yet to be undertaken. Objective The objective is to investigate the feasibility of a nested randomized controlled trial (RCT) alongside a longitudinal observational study of physical activity and exercise outcomes in people with HD. Design This will be a 12-month longitudinal observational study (n = 120) with a nested evaluation of a physical activity intervention (n = 30) compared with usual activity (n = 30) using a “trial within a cohort” design. Setting The study will take place in HD specialist clinics in Germany, Spain, and the United States, with intervention delivery in community settings. Participants The participants will have early-mid–stage HD and be participating in the Enroll-HD study. Intervention This will be a 12-month physical activity behavioral change intervention, delivered by physical therapists in 18 sessions, targeting uptake of aerobic exercise and increased physical activity. Measurements All participants (n = 120) will complete Enroll-HD assessments (motor, cognitive, behavioral, and quality of life) at baseline and at 12 months. Additional Physical ACtivity and Exercise Outcomes in Huntington Disease (PACE-HD) assessments include fitness (predicted maximal oxygen uptake [V  o2max]), self-reported and quantitative measures of physical activity, disease-specific symptoms, and walking endurance. RCT participants (n = 60) will complete an additional battery of quantitative motor assessments and a 6-month interim assessment. Enroll-HD data will be linked to PACE-HD physical activity and fitness data. Limitations The limitations include that the embedded RCT is open, and assessors at RCT sites are not blinded to participant allocation. Conclusion PACE-HD will enable determination of the feasibility of long-term physical activity interventions in people with HD. The novel “trial within a cohort” design and incorporation of data linkage have potential to reduce participant burden. This design could be applied to other neurological diseases and movement disorders where recruitment and retention are challenging.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Centre for Trials Research (CNTRR) Medicine
Publisher:	Oxford University Press (OUP): Policy B - Oxford Open Option D - CC-BY
ISSN:	0031-9023
Date of First Compliant Deposit:	22 August 2019
Date of Acceptance:	18 February 2019
Last Modified:	15 Apr 2024 16:30
URI:	https://orca.cardiff.ac.uk/id/eprint/125074

Citation Data

Cited 7 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item